Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Delayed pentobarbital administration limits ischemic brain damage in gerbils.

D E Levy, J B Brierley

    Annals of Neurology
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Differential effect by chronic disease risk: A secondary analysis of the ChooseWell 365 randomized controlled trial.

    Preventive medicine reports·2024
    Same author

    Seasonal variability in environmental tobacco smoke exposure in public housing developments.

    Indoor air·2014
    Same author

    STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia.

    Mucosal immunology·2012
    Same author

    Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
    Same author

    Spinal pumping.

    British medical journal·2010
    Same author

    Spinal pumping.

    British medical journal·2010

    This study investigates whether giving a sedative drug called pentobarbital one hour after a stroke can reduce brain injury. Researchers tested this in gerbils that experienced a temporary blockage of blood flow to the brain. They found that animals treated with the drug showed significantly less brain tissue damage and fewer signs of swelling compared to those given a placebo. These findings suggest that there may be a window of time after a stroke where medical intervention can still help protect brain cells.

    Area of Science:

    • Neuropathology and pentobarbital neuroprotection research
    • Cerebral ischemia clinical studies

    Background:

    No prior work had resolved if delayed sedative treatment effectively mitigates neurological injury following temporary blood flow restriction. That uncertainty drove this investigation into the therapeutic potential of barbiturates. Prior research has shown that immediate intervention often provides neuroprotection, yet clinical scenarios frequently involve significant delays. This gap motivated the current assessment of a one-hour post-ischemic treatment window. Scientists have long sought to extend the timeframe for effective stroke management. Previous models often focused on pre-treatment or immediate post-injury administration. The current study addresses the practical limitations of rapid medical response. Understanding these temporal boundaries remains a priority for developing effective neuroprotective strategies.

    Purpose Of The Study:

    The aim of this study was to evaluate the capacity of delayed barbiturate administration to limit brain damage following unilateral cerebral ischemia. Researchers sought to determine if pharmacological intervention could remain effective when initiated one hour after the cessation of blood flow restriction. This investigation addressed the practical challenge of providing timely treatment in stroke scenarios. The authors hypothesized that a therapeutic window exists beyond the immediate post-ischemic period. By comparing treated gerbils to a placebo group, the team examined the extent of neuronal cell death. They specifically investigated whether pentobarbital could mitigate structural shifts and infarction. The study was motivated by the need to identify interventions that function within realistic clinical timeframes. This work provides a controlled assessment of how delayed drug delivery influences neurological outcomes in a laboratory setting.

    Keywords:
    neuroprotectioncerebral infarctionbarbituratesstroke model

    Frequently Asked Questions

    The researchers propose that pentobarbital limits ischemic damage by reducing neuronal cell change and midline structural shifts. Treated subjects received 70 mg/kg initially followed by 50 mg/kg two hours later, whereas the placebo group received only normal saline.

    The study utilized sodium pentobarbital as the primary neuroprotective agent. In contrast, the control group received equivalent volumes of normal saline to ensure identical handling during the post-ischemic observation period.

    The right common carotid artery was occluded for one hour to induce ischemia. This specific duration was necessary to consistently produce motor abnormalities in 36% of the 50 gerbils, allowing for a controlled comparison between treatment and placebo groups.

    Related Experiment Videos

    Main Methods:

    The review approach involved a controlled experimental design using 50 gerbils subjected to temporary right common carotid artery occlusion. Researchers maintained brief halothane anesthesia during the initial surgical procedure. Animals exhibiting motor abnormalities were randomly assigned to either a treatment or placebo cohort. The treatment group received intraperitoneal injections of sodium pentobarbital one hour after arterial clasp removal. A secondary dose was administered two hours following the initial injection. Investigators ensured all subjects remained normothermic throughout the observation period. Perfusion-fixation was performed twenty-four hours post-ischemia to prepare brain tissue for detailed pathological analysis. This systematic process allowed for a direct comparison of neuronal health between the two experimental groups.

    Main Results:

    Key findings from the literature indicate that pentobarbital treatment significantly reduces ischemic damage compared to saline-treated controls. Histological analysis revealed fewer instances of midline structural shifts in the treated cohort. Five specific regions within the ipsilateral cerebral hemisphere showed less extensive neuronal ischemic cell change. Statistical analysis confirmed these differences reached a significance level of p less than 0.05. The study observed that 36% of the initial 50 animals developed motor abnormalities consistent with stroke. Both groups displayed similar post-ischemic motor behavior throughout the observation period. Treated subjects lost corneal reflexes but maintained spontaneous respiration during the intervention. These results suggest that pharmacological protection remains viable even when initiated sixty minutes after the ischemic insult concludes.

    Conclusions:

    The authors propose that barbiturate administration remains effective even when initiated one hour after the cessation of ischemic insult. This synthesis suggests a broader therapeutic window than previously assumed for mitigating secondary brain injury. The findings imply that pharmacological intervention can successfully reduce the extent of neuronal cell death in specific cerebral regions. Observations indicate that treated subjects exhibited fewer midline structural shifts compared to the placebo group. The study demonstrates that pentobarbital treatment correlates with reduced infarction severity following temporary arterial occlusion. These results provide evidence that post-ischemic recovery can be influenced by delayed drug delivery. The researchers conclude that their data support the potential for neuroprotective benefits in delayed treatment scenarios. Future clinical applications might benefit from recognizing this extended period for intervention.

    The researchers employed histological examination of brain tissue following perfusion-fixation. This data type allowed for the quantification of ischemic cell change across five distinct regions of the ipsilateral cerebral hemisphere, providing a clear metric for comparing treatment efficacy.

    The study measured the presence of midline structural shifts and the extent of ipsilateral infarction. Pentobarbital-treated animals showed significantly less damage in these areas compared to the placebo group, with statistical significance noted at p less than 0.05.

    The authors suggest that barbiturates administered up to one hour after an ischemic event can still limit brain damage. This implies that the therapeutic window for neuroprotection might be longer than previously established in earlier models of cerebral ischemia.